Daxor Corporation, a medical device company, provides biotechnology and cryobanking services in the United States. The company offers BVA-100 Blood Volume Analyzer, an instrument that measures blood volume in human body. BVA-100 Blood Volume Analyzer is used to diagnose and treat patients in various medical and surgical conditions, including congestive heart failure, critical care medicine and intensive care unit medicine, hypertension, syncope, pre-operative blood screening for hidden anemia, anemia in cancer patients, kidney failure, and hyponatremia. It also provides semen banking, blood storage, andrology, and general lab testing services. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was founded in 1970 and is headquartered in New York, New York.
Industry, Sector and Symbol
Industry Medical Instruments & Supplies
Sub-IndustryN/A
SectorMedical
Phone+1-212-3308500
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable
Daxor (NYSEAMERICAN:DXR) Frequently Asked Questions
What is Daxor's stock symbol?
Daxor trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "DXR."
What price target have analysts set for DXR?
2 Wall Street analysts have issued twelve-month price targets for Daxor's stock. Their predictions range from $20.00 to $22.00. On average, they expect Daxor's share price to reach $21.00 in the next twelve months. This suggests a possible upside of 140.0% from the stock's current price. View Analyst Price Targets for Daxor.
What is the consensus analysts' recommendation for Daxor?
2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Daxor in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Daxor.
Has Daxor been receiving favorable news coverage?
Media stories about DXR stock have been trending positive this week, according to InfoTrie Sentiment. InfoTrie scores the sentiment of press coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Daxor earned a media sentiment score of 2.5 on InfoTrie's scale. They also gave news stories about the company a news buzz of 6.0 out of 10, meaning that recent press coverage is somewhat likely to have an impact on the company's share price in the next several days. View News Stories for Daxor.
Are investors shorting Daxor?
Daxor saw a drop in short interest in the month of July. As of July 31st, there was short interest totalling 89,500 shares, a drop of 5.9% from the June 30th total of 95,100 shares. Based on an average daily volume of 8,100 shares, the short-interest ratio is presently 11.0 days. Currently, 11.4% of the shares of the stock are sold short. View Daxor's Current Options Chain.
Who are some of Daxor's key competitors?
Some companies that are related to Daxor include Tristel (TSTL), InfuSystem (INFU), SDI (SDI), Impression Healthcare (IHL), G Medical (GMV), TSO3 (TOS), IsoRay (ISR), Retractable Technologies (RVP), Milestone Scientific (MLSS), IsoRay (ISR), Omega Diagnostics Group (ODX), Relevium Technologies (RLV), Akers Biosciences (AKR), Vigil Health Solutions (VGL) and ANSELL LTD/S (ANSLY).
What other stocks do shareholders of Daxor own?
Who are Daxor's key executives?
Daxor's management team includes the folowing people:
- Mr. Michael Richard Feldschuh, Chairman, Pres & CEO (Age 50)
- Mr. Jonathan Adam Feldschuh, Chief Scientific Officer & Director (Age 54)
- Mr. Robert J. Michel CPA, Chief Financial Officer (Age 62)
- Ms. Kathryn A. Kornafel, VP of Marketing & Commercial Devel.
- Mr. Guido Manzo, VP of Sales
How do I buy shares of Daxor?
Shares of DXR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Daxor's stock price today?
One share of DXR stock can currently be purchased for approximately $8.75.
How big of a company is Daxor?
What is Daxor's official website?
How can I contact Daxor?
Daxor's mailing address is 350 5th Ave Ste 4740, NEW YORK, NY 10118-0002, United States. The company can be reached via phone at +1-212-3308500.
MarketBeat Community Rating for Daxor (NYSEAMERICAN DXR)
MarketBeat's community ratings are surveys of what our community members think about Daxor and other stocks. Vote "Outperform" if you believe DXR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe DXR will underperform the S&P 500 over the long term. You may vote once every thirty days.
